Hemispherx Biopharma (HEB) Reports Q3 Loss of $0.30/Share

November 14, 2016 4:37 PM EST
Get Alerts HEB Hot Sheet
Price: $0.17 --0%

Financial Fact:
Research and development: 900K

Today's EPS Names:
BSET, BMTC, JBHT, More
Trade HEB Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Hemispherx Biopharma (NYSE: HEB) reported Q3 EPS of ($0.30), versus ($0.62) reported last year.

For earnings history and earnings-related data on Hemispherx Biopharma (HEB) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment